Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

被引:40
作者
Koirala, S. [1 ]
Borisov, S. [2 ]
Danila, E. [3 ]
Mariandyshev, A. [4 ]
Shrestha, B. [5 ]
Lukhele, N. [6 ]
Dalcolmo, M. [7 ]
Shakya, S. R. [8 ]
Miliauskas, S. [9 ]
Kuksa, L. [10 ]
Manga, S. [11 ]
Aleksa, A. [12 ]
Denholm, J. T. [13 ]
Khadka, H. B. [14 ]
Skrahina, A. [15 ]
Diktanas, S. [16 ]
Ferrarese, M. [17 ]
Bruchfeld, J. [18 ,19 ]
Koleva, A. [20 ]
Piubello, A.
Koirala, G. S. [22 ]
Udwadia, Z. F. [23 ]
Palmero, D. J. [24 ]
Munoz-Torrico, M. [25 ]
Gc, R. [26 ]
Gualano, G. [27 ]
Grecu, V., I [28 ]
Motta, I [29 ]
Papavasileiou, A. [30 ]
Li, Y. [31 ]
Hoefsloot, W. [32 ]
Kunst, H. [33 ]
Mazza-Stalder, J. [34 ]
Payen, M-C [35 ]
Akkerman, O. W. [36 ,37 ]
Bernal, E. [38 ]
Manfrin, V [39 ]
Matteelli, A. [40 ]
Hamdan, H. Mustafa [41 ]
Marcos, M. Nieto [42 ]
Cadinanos Loidi, J. [43 ]
Cebrian Gallardo, J. J. [44 ]
Duarte, R. [45 ]
Escobar Salinas, N. [46 ]
Gomez Rosso, R. [47 ]
Laniado-Laborin, R. [48 ,49 ]
Martinez Robles, E. [50 ]
Quiros Fernandez, S. [51 ]
Rendon, A. [52 ]
Solovic, I [53 ]
机构
[1] Damien Fdn Nepal, Kathmandu, Nepal
[2] Moscow Govts Hlth Dept, Moscow Res & Clin Ctr TB Control, Moscow, Russia
[3] Vilnius Univ, Vilnius Univ Hosp Santaros Klin, Ctr Pulmonol & Allergol, Clin Chest Dis Immunol & Allergol,Med Fac, Vilnius, Lithuania
[4] Northern State Med Univ, Northern Arctic Fed Univ, Arkhangelsk, Russia
[5] Kalimati Chest Hosp, GENETUP, Nepal Anti TB Assoc, Kathmandu, Nepal
[6] World Hlth Org, TB HIV Hepatitis & PMTCT Dept, Eswatini WHO Country Off, Mbabane, Eswatini
[7] Minist Hlth, Fundacao Oswaldo Cruz Fiocruz, Reference Ctr Helio Fraga, Rio De Janeiro, Brazil
[8] Lumbini Prov Hosp, Butwal, Nepal
[9] Lithuanian Univ Hlth Sci, Dept Pulmonol, Kaunas, Lithuania
[10] Riga East Univ Hosp, MDR TB Dept, TB & Lung Dis Ctr, Riga, Latvia
[11] Univ Natl San Antonio Abad Cusco, Dept Infect Dis, Cuzco, Peru
[12] Grodno State Med Univ, Dept Phthisiol & Pulmonol, Grodno, BELARUS
[13] Univ Melbourne, Dept Infect Dis, Melbourne Hlth, Victorian TB Program, Melbourne, Vic, Australia
[14] TB Nepal, Nepalgjunj TB Referral Ctr, Nepalganj, Nepal
[15] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS
[16] Republican Klaip Hosp, TB Dept, TB Unit 3, Klaipeda, Lithuania
[17] Osped Niguarda Ca Granda, TB Reference Ctr, Villa Marelli Inst, Milan, Italy
[18] Dept Med, Div Infect Dis, Solna, Sweden
[19] Karolinska Univ Hosp, Karolinska Inst, Dept Infect Dis, Stockholm, Sweden
[20] Gabrovo Lung Dis Hosp, Pulmonol & Physiotherapy Dept, Gabrovo, Bulgaria
[21] Damien Fdn, Niamey, Niger
[22] Nepal Anti TB Assoc, TB Clin, Morang Branch, Biratnagar 1, Nepal
[23] PD Hinduja Natl Hosp & MRC, Dept Resp Med, Mumbai, Maharashtra, India
[24] Municipal Hosp FJ Muniz, Pulmonol Div, Buenos Aires, DF, Argentina
[25] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Clin TB, Ciudad De Mexico, Mexico
[26] Midpoint Dist Community Mem Hosp, Damien Fdn, Danda, Nawalparasi, Nepal
[27] IRCCS, Resp Infect Dis Unit, Natl Inst Infect Dis L Spallanzani, Rome, Italy
[28] Natl Programme Prevent Surveillance & Control TB, Craiova, Dolj Province, Romania
[29] Univ Torino, Dept Med Sci, Unit Infect Dis, Turin, Italy
[30] Sotiria Athens Hosp Chest Dis, Dept TB, Athens, Greece
[31] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China
[32] Radboud Univ Nijmegen Med Ctr, Ctr Dekkerswald, Nijmegen, Netherlands
[33] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[34] Univ Hosp Lausanne CHUV, Div Pulm Med, Lausanne, Switzerland
[35] Univ Libre Bruxelles ULB, Div Infect Dis, CHU St Pierre, Brussels, Belgium
[36] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands
[37] Univ Groningen, Univ Med Ctr Groningen, TB Ctr Beatrixoord, Haren, Netherlands
[38] Hosp Gen Univ Reina Sofia, Unidad Enfermedades Infecciosas, Murcia, Spain
[39] S Bortolo Hosp, Infect & Trop Dis Operating Unit, Vicenza, Italy
[40] Univ Brescia, WHO Collaborating Ctr TB Eliminat & TB HIV Coinfe, Clin Infect & Trop Dis, Brescia, Italy
[41] Abu Anga Teaching Hosp, MDR TB Dept, Khartoum, Sudan
[42] Hosp Doctor Moliner, Internal Med Dept, Valencia, Spain
[43] Hosp Gen Villalba, Internal Med Dept, Collado Villalba, Spain
[44] Agencia Sanitaria Costa del Sol, Unidad Neumol, Marbella, Spain
[45] Univ Porto, Hosp Ctr Vila Nova de Gaia, Fac Med, Natl Reference Ctr MDR TB,Dept Pneumol,Publ Hlth, Porto, Portugal
[46] Minist Hlth Santiago, Div Dis Prevent & Control, Dept Communicable Dis, Natl TB Control & Eliminat Programme, Santiago, Chile
[47] Natl Inst Resp & Environm Dis Prof Dr Juan Max Bo, Asuncion, Paraguay
[48] Univ Autonoma Baja California, Mexicali, Baja California, Mexico
[49] Hosp Gen Tijuana, Clin TB, Tijuana, Baja California, Mexico
[50] Hosp Gen Univ La Paz, Internal Med Dept, Hosp Cantoblanco, Madrid, Spain
关键词
Tuberculosis; MDR-TB; Delamanid; Bedaquiline; Treatment outcomes; Prevention of TB sequelae; TUBERCULOSIS; REHABILITATION; ACCESS; EXPERIENCES; SEQUELAE; PROGRESS; NEED;
D O I
10.1016/j.pulmoe.2021.02.006
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively evaluate the effectiveness of bedaquiline (and/or delamanid)- containing regimens in a large cohort of consecutive TB patients treated globally. This observational, prospective study is based on data collected and provided by Global Tuberculosis Network (GTN) centres and analysed twice a year. All consecutive patients (including children/adolescents) treated with bedaquiline and/or delamanid were enrolled, and managed according to WHO and national guidelines. Overall, 52 centres from 29 countries/regions in all continents reported 883 patients as of January 31st 2021, 24/29 countries/regions providing data on 100% of their consecutive patients (10-80% in the remaining 5 countries). The drug-resistance pattern of the patients was severe (>30% with extensively drug-resistant -TB; median number of resistant drugs 5 (3-7) in the overall cohort and 6 (4-8) among patients with a final outcome). For the patients with a final outcome (477/883, 54.0%) the median (IQR) number of months of anti-TB treatment was 18 (13-23) (in days 553 (385-678)). The proportion of patients achieving sputum smear and culture conversion ranged from 93.4% and 92.8% respectively (whole cohort) to 89.3% and 88.8% respectively (patients with a final outcome), a median (IQR) time to sputum smear and culture conversion of 58 (30-90) days for the whole cohort and 60 (30-100) for patients with a final outcome and, respectively, of 55 (30-90) and 60 (30-90) days for culture conversion. Of 383 patients treated with bedaquiline but not delamanid, 284 (74.2%) achieved treatment success, while 25 (6.5%) died, 11 (2.9%) failed and 63 (16.5%) were lost to follow-up. (C) 2021 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 49 条
[1]   Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis [J].
Ahmad, Nafees ;
Ahuja, Shama D. ;
Akkerman, Onno W. ;
Alffenaar, Jan-Willem C. ;
Anderson, Laura F. ;
Baghaei, Parvaneh ;
Bang, Didi ;
Barry, Pennan M. ;
Bastos, Mayara L. ;
Behera, Digamber ;
Benedetti, Andrea ;
Bisson, Gregory P. ;
Boeree, Martin J. ;
Bonnet, Maryline ;
Brode, Sarah K. ;
Brust, James C. M. ;
Cai, Ying ;
Caumes, Eric ;
Cegielski, J. Peter ;
Centis, Rosella ;
Chan, Pei-Chun ;
Chan, Edward D. ;
Chang, Kwok-Chiu ;
Charles, Macarthur ;
Cirule, Andra ;
Dalcolmo, Margareth Pretti ;
D'Ambrosio, Lia ;
de Vries, Gerard ;
Dheda, Keertan ;
Esmail, Aliasgar ;
Flood, Jennifer ;
Fox, Gregory J. ;
Frechet-Jachym, Mathilde ;
Fregona, Geisa ;
Gayoso, Regina ;
Gegia, Medea ;
Gler, Maria Tarcela ;
Gu, Sue ;
Guglielmetti, Lorenzo ;
Holtz, Timothy H. ;
Hughes, Jennifer ;
Isaakidis, Petros ;
Jarlsberg, Leah ;
Kempker, Russell R. ;
Keshavjee, Salmaan ;
Khan, Faiz Ahmad ;
Kipiani, Maia ;
Koenig, Serena P. ;
Koh, Won-Jung ;
Kritski, Afranio .
LANCET, 2018, 392 (10150) :821-834
[2]   Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study [J].
Akkerman, Onno ;
Aleksa, Alena ;
Alffenaar, Jan-Willem ;
Al-Marzouqi, Nada Hassan ;
Arias-Guillen, Miguel ;
Belilovski, Evgeny ;
Bernal, Enrique ;
Boeree, Martin J. ;
Borisov, Sergey E. ;
Bruchfeld, Judith ;
Cadinanos Loidi, Julen ;
Cai, Qingshan ;
Caminero, Jose A. ;
Cebrian Gallardo, Jose Joaquin ;
Centis, Rosella ;
Codecasa, Luigi Ruffo ;
D'Ambrosio, Lia ;
Dalcolmo, Margareth ;
Danila, Edvardas ;
Dara, Masoud ;
Davidaviciene, Edita ;
Forsman, Lina Davies ;
Rios Jefe, Jorge De Los ;
Denholm, Justin ;
Duarte, Raquel ;
Elamin, Seifeldin Eltaeb ;
Ferrarese, Maurizio ;
Filippov, Alexey ;
Ganatra, Shashank ;
Garcia, Ana ;
Garcia-Garcia, Jose-Maria ;
Gayoso, Regina ;
Giraldo Montoya, Angela Maria ;
Gomez Rosso, Roscio Gomez ;
Gualano, Gina ;
Hoefsloot, Wouter ;
Ilievska-Poposka, Biljana ;
Jonsson, Jerker ;
Khimova, Elena ;
Kuksa, Liga ;
Kunst, Heinke ;
Laniado-Laborin, Rafael ;
Li, Yang ;
Magis-Escurra, Cecile ;
Manfrin, Vinicio ;
Manga, Selene ;
Marchese, Valentina ;
Martinez Robles, Elena ;
Maryandyshev, Andrei ;
Matteelli, Alberto .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 83 :72-76
[3]   Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients [J].
Akkerman, Onno W. ;
ter Beek, Lies ;
Centis, Rosella ;
Maeurer, Markus ;
Visca, Dina ;
Munoz-Torrico, Marcela ;
Tiberi, Simon ;
Migliori, Giovanni Battista .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 92 :S10-S14
[4]   What is behind programmatic treatment outcome definitions for tuberculosis? [J].
Avaliani, Zaza ;
Gozalov, Ogtay ;
Kuchukhidze, Giorgi ;
Skrahina, Alena ;
Soltan, Viorel ;
van den Boom, Martin ;
Vasilyeva, Irina ;
Vilc, Valentina ;
Yedilbayev, Askar .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (01)
[5]   Introduction and scaling up of new drugs for drug-resistant TB: experiences from the Americas [J].
Bernal, O. ;
Lopez, R. ;
Montoro, E. ;
Avedillo, P. ;
Westby, K. ;
Ghidinelli, M. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (10) :1058-+
[6]   Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report [J].
Borisov, Sergey ;
Danila, Edvardas ;
Maryandyshev, Andrei ;
Dalcolmo, Margareth ;
Miliauskas, Skaidrius ;
Kuksa, Liga ;
Manga, Selene ;
Skrahina, Alena ;
Diktanas, Saulius ;
Codecasa, Luigi Ruffo ;
Aleksa, Alena ;
Bruchfeld, Judith ;
Koleva, Antoniya ;
Piubello, Alberto ;
Udwadia, Zarir Farokh ;
Akkerman, Onno W. ;
Belilovski, Evgeny ;
Bernal, Enrique ;
Boeree, Martin J. ;
Cadinanos Loidi, Julen ;
Cai, Qingshan ;
Cebrian Gallardo, Jose Joaquin ;
Dara, Masoud ;
Davidaviciene, Edita ;
Forsman, Lina Davies ;
De Los Rios, Jorge ;
Denholm, Justin ;
Draksiene, Jacinta ;
Duarte, Raquel ;
Elamin, Seifeldin Eltaeb ;
Escobar Salinas, Nadia ;
Ferrarese, Maurizio ;
Filippov, Alexey ;
Garcia, Ana ;
Garcia-Garcia, Jose-Maria ;
Gaudiesiute, Ieva ;
Gavazova, Blagovesta ;
Gayoso, Regina ;
Rosso, Roscio Gomez ;
Gruslys, Vygantas ;
Gualano, Gina ;
Hoefsloot, Wouter ;
Jonsson, Jerker ;
Khimova, Elena ;
Kunst, Heinke ;
Laniado-Laborin, Rafael ;
Li, Yang ;
Magis-Escurra, Cecile ;
Manfrin, Vinicio ;
Marchese, Valentina .
EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (06)
[7]   Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery [J].
Borisov, Sergey E. ;
D'Ambrosio, Lia ;
Centis, Rosella ;
Tiberi, Simon ;
Dheda, Keertan ;
Alffenaar, Jan-Willem ;
Amale, Rohit ;
Belilowski, Evgeny ;
Bruchfeld, Judith ;
Canneto, Barbara ;
Denholm, Justin ;
Duarte, Raquel ;
Esmail, Aliasgar ;
Filippov, Alex ;
Forsman, Lina Davies ;
Gaga, Mina ;
Ganatra, Shashank ;
Igorevna, Gaida Anastasia ;
Mastrapa, Barbara Lazaro ;
Manfrin, Vinicio ;
Manga, Selene ;
Maryandyshev, Andrey ;
Massard, Gilbert ;
Gonzalez Montaner, Pablo ;
Mullerpattan, Jai ;
Juan Palmero, Domingo ;
Pontarelli, Agostina ;
Papavasileiou, Apostolos ;
Pontali, Emanuele ;
Leyet, Rodolfo Romero ;
Spanevello, Antonio ;
Udwadia, Zarir Farokh ;
Viggiani, Pietro ;
Visca, Dina ;
Sotgiu, Giovanni ;
Migliori, Giovanni Battista .
JOURNAL OF INFECTION, 2019, 78 (01) :35-39
[8]   Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study [J].
Borisov, Sergey E. ;
Dheda, Keertan ;
Enwerem, Martin ;
Leyet, Rodolfo Romero ;
D'Ambrosio, Lia ;
Centis, Rosella ;
Sotgiu, Giovanni ;
Tiberi, Simon ;
Alffenaar, Jan-Willem ;
Maryandyshev, Andrey ;
Belilovski, Evgeny ;
Ganatra, Shashank ;
Skrahina, Alena ;
Akkerman, Onno ;
Aleksa, Alena ;
Amale, Rohit ;
Artsukevich, Janina ;
Bruchfeld, Judith ;
Caminero, Jose A. ;
Carpena Martinez, Isabel ;
Codecasa, Luigi ;
Dalcolmo, Margareth ;
Denholm, Justin ;
Douglas, Paul ;
Duarte, Raquel ;
Esmail, Aliasgar ;
Fadul, Mohammed ;
Filippov, Alexey ;
Forsman, Lina Davies ;
Gaga, Mina ;
Garcia-Fuertes, Julia-Amaranta ;
Garcia-Garcia, Jose-Maria ;
Gualano, Gina ;
Jonsson, Jerker ;
Kunst, Heinke ;
Lau, Jillian S. ;
Mastrapa, Barbara Lazaro ;
Troya, Jorge Lazaro Teran ;
Manga, Selene ;
Manika, Katerina ;
Gonzalez Montaner, Pablo ;
Mullerpattan, Jai ;
Oelofse, Suzette ;
Ortelli, Martina ;
Juan Palmero, Domingo ;
Palmieri, Fabrizio ;
Papalia, Antonella ;
Papavasileiou, Apostolos ;
Payen, Marie-Christine ;
Pontali, Emanuele .
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
[9]   Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country [J].
Chesov, Dumitru ;
Heyckendorf, Jan ;
Alexandru, Sofia ;
Donica, Ana ;
Chesov, Elena ;
Reimann, Maja ;
Crudu, Valeriu ;
Botnaru, Victor ;
Lange, Christoph .
EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (06)
[10]   A Short Regimen for Rifampin-Resistant Tuberculosis [J].
Churchyard, Gavin J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (13) :1279-1280